|
|
| Line 1: |
Line 1: |
| __NOTOC__
| | #REDIRECT [[Mexiletine#Package and Label Display Panel]] |
| {{Mexiletine}}
| |
| {{CMG}}; {{AE}} {{SS}}; {{AZ}}
| |
| | |
| ==Labels And Packages==
| |
| | |
| {|
| |
| |[[File:Mexilitine 150mg.PNG|thumb|600px]]
| |
| |}
| |
| | |
| {|
| |
| |[[File:Mexilitine 200mg.PNG|thumb|600px]]
| |
| |}
| |
| | |
| {|
| |
| |[[File:Mexilitine 250mg.JPG|thumb|600px]]
| |
| |}
| |
| .<ref name="dailymed.nlm.nih.gov">{{Cite web | last = | first = | title = MEXILETINE HYDROCHLORIDE CAPSULE [TEVA PHARMACEUTICALS USA INC] | url = http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=693da40b-26d4-40d6-87d1-158e256f40ab | publisher = | date = | accessdate = 3 March 2014 }}</ref>
| |
| | |
| ==References==
| |
| | |
| {{Reflist}}
| |
| | |
| {{Antiarrhythmic agents}}
| |
| | |
| [[Category:Sodium channel blockers]]
| |
| [[Category:Phenol ethers]]
| |
| [[Category:Cardiovascular Drugs]]
| |
| [[Category:Drugs]]
| |